一个注意力意识的多任务学习框架识别了在萨尔科佩尼亚中药物重定位的候选目标
Md Selim Reza1, Chuan Qiu1, Xu Lin2
1Deming Department of Medicine, School of Medicine, Tulane Center for Biomedical Informatics and Genomics, Tulane University, New Orleans, Louisiana, USA.
Journal of cachexia, sarcopenia and muscle
|March 6, 2025
概括
萨尔科佩尼亚是一种与年龄相关的肌肉衰退状况,缺乏药物治疗. 一种新的多omics方法通过向PTK2B蛋白来确定canagliflozin作为一种潜在的治疗方法.
科学领域:
- 基因组学和生物信息学
- 衰老研究研究 衰老研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 萨科佩尼亚是一个与衰老相关的重大公共卫生问题,导致肌肉质量和力量的下降.
- 目前对肉类的治疗方法有限,这凸显了迫切需要新的药理干预措施.
研究的目的:
- 开发一种新的计算方法,用于识别药物标和治疗萨尔科佩尼亚.
- 分析多omics数据,蛋白质-蛋白质相互作用和药物向网络,以发现新的治疗策略.
主要方法:
- 开发了一种多任务注意力意识的多omics数据 (MTA-MO) 方法,以整合转录组,甲基组和基因组数据.
- 该MTA-MO方法包括人类蛋白质与蛋白质相互作用 (PPI) 和药物向网络,以加强向识别.
- 该方法应用于1055名参与者的数据集,分析了遗传,表观遗传和临床数据.
主要成果:
- 这项研究确定了七个潜在的与肉症相关的枢纽基因,包括ESR1,ATM,CDC42,EP300,PIK3CA,EGF和PTK2B.
- 路径分析揭示了关键功能和信号路径,这些路径与骨肌肉健康有关.
- 在基选中,卡纳格里夫洛辛被确定为一个有前途的候选药物,显示出对PTK2B.有强烈的结合亲和力.
结论:
- 开发的MTA-MO方法有效地整合了用于萨科佩尼亚研究的多omics数据.
- 卡纳格利弗洛辛显示出作为治疗萨尔科佩尼亚的治疗剂的潜力,这需要进一步的研究.
更多相关视频
相关概念视频
01:28Structure-Activity Relationships and Drug Design
474
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
474
01:26Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
01:26Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K